PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Symptom | |diabetes |
| Sentences | 526 |
| PubMedID- 20040043 | to suggest that rosiglitazone may contribute to a decrease in the development of vascular diseases associated with type 2 diabetes mellitus through actions on pecam-1. |
| PubMedID- 21525477 | Minor reductions in egfr are linked to increased risk for renal and cardiovascular disease in patients with diabetes as well. |
| PubMedID- 26107641 | Patients had multiple risk factors at inclusion on renal transplantation waiting list as high blood pressure (94.7%), dyslipidemia (81.1%), smoking (45.3%), diabetes (23.6%), past history of cardiovascular disease (21.3%) and obesity (12.7%). |
| PubMedID- 23140093 | Micro- and macrovascular disease associated with diabetes and/or treatment for diabetes may also put these patients at a higher risk of fracture-healing complications; for example, thiazolidinidiones have been shown to be associated with an increased risk of fracture (dormuth et al. |
| PubMedID- 22258465 | diabetes is associated with high cardiovascular disease (cvd) morbidity, especially in patients with ckd. |
| PubMedID- 22125626 | The relationship between vascular diseases and hua in patients with type 2 diabetes has not been fully explored. |
| PubMedID- 23251757 | Reduction of low-density lipoprotein cholesterol (ldl-c) with statins is highly effective in reducing cardiovascular disease in patients with and without diabetes, but leaves unaddressed a sizeable residual vascular risk (rvr), which is rarely quantified in routine clinical practice. |
| PubMedID- 26385225 | Two points were assigned for recent hospitalization or intensive care unit (icu) admission and one point was assigned for each of the following: age <30 or >79 years, prior intravenous (iv) antibiotics in last 30 days, dementia, cardiovascular disease, female with diabetes, or recent exposure to a nursing home, long-term care facility, or skilled nursing facility. |
| PubMedID- 26312908 | Interpretation: this study suggests that associations of type 2 diabetes vary with different incident cardiovascular diseases. |
| PubMedID- 20448009 | Background: resting heart rate has been shown to predict risk of cardiovascular disease; its association with diabetes remains unclear, particularly in non-western populations. |
| PubMedID- 24757888 | The prevalence of many of the co-morbidities assessed is statistically the same in pre-diabetes patients with only peripheral vascular disease, eye disease and cerebrovascular disease having a statistically significant higher prevalence in type 2 diabetes. |
| PubMedID- 19664902 | Changes in certification of diabetes with cardiovascular diseases increased reported diabetes mortality in australia and the united states. |
| PubMedID- 22194960 | Individuals with pre-diabetes often bear clusters of cardiovascular disease risk factors 1. |
| PubMedID- 24465050 | And, would monotherapy with either or both of those drugs reduce the risk of cardiovascular disease events in patients with type 2 diabetes mellitus? |
| PubMedID- 19859073 | The burden of microvascular disease in patients with type 2 diabetes mellitus continues to escalate worldwide. |
| PubMedID- 23162979 | diabetes screening as part of a vascular disease risk management programme. |
| PubMedID- 25799396 | When clinical characteristics (age, gender, smoking, hypertension, diabetes, activity of disease, cardiovascular disease, obesity, menopausal status) between dyslipidemic and non-dyslipidemic cs patients were compared, to explain shorter tl in dyslipidemic cs patients, the former were older (dyslipidemic 53±11.7 years vs non dyslipidemic 45±12.7 years, p < 0.05) and more frequently obese (49% vs. 34% in non-dyslipidemic cs patients, p < 0.05); these differences persisted after adjustment for bmi and age (7313±1210 vs 7873±1182 bp, p <0.05). |
| PubMedID- 25099744 | Objective: dyslipidemia contributes to the increased risk of cardiovascular disease in persons with type 1 diabetes (t1d). |
| PubMedID- 24843460 | In contrast, the accord study showed that type 2 diabetes subjects (with cardiovascular disease or at least two risk factors for cardiovascular disease or severe atherosclerosis) who underwent intensive glycemic control (target hba1c < 6.0%) showed rather increased mortality (hazard ratio 1.22) compared with those who received standard glycemic control (target hba1c 7.0–7.9%), and thus warned of the unexpected risk of strict glycemic control7. |
| PubMedID- 22035298 | However, limited information exists with regard to cardiovascular disease risk in patients with diabetes and renal dysfunction, particularly after ami. |
| PubMedID- 23540820 | Screening for peripheral vascular disease in patients with type 2 diabetes in malta in a primary care setting. |
| PubMedID- 23856609 | However, vegf therapy is not very effective in models of cardiovascular diseases associated with diabetes, and the mechanisms of this phenomenon still remain to be elucidated. |
| PubMedID- 22430605 | In view of the high incidence of macrovascular diseases in patients with type 2 diabetes mellitus and microalbuminuria, the study evaluates the association of microalbuminuria with fasting plasma apo b48 levels, a marker of the residual presence of intestinally derived trls lipoproteins, thought to be highly atherogenic. |
| PubMedID- 21654912 | From as early as the 1970s, the world health organization multicentre vascular disease in diabetes survey demonstrated the propensity of asian populations to develop stroke and end-stage renal disease (esrd) whereas whites were more likely to develop chd . |
| PubMedID- 23431014 | diabetes doubles the risk of cardiovascular disease (cvd) independently of other risk factors (1). |
| PubMedID- 22850257 | Hazard ratio (hr) with 95% confidence interval (ci) for the elderly diabetes associated with cardiovascular disease (cvd), hip fracture, and lower extremity amputation was 1.13 (1.04-1.23), 1.10 (0.91-1.34), and 1.25 (0.95-1.65), respectively. |